Ann: Emyria Pursuing Registration of EMD-003 in CY2021, page-14

Emyria’s strategy is to generate high quality, ethically-sourced real-world and clinical evidence,
called Emyria Data.

Emyria Data is generated within Emyria’s Emerald Clinics from consenting patients
and currently contains 2.6M, anonymised data points - and growing.

Emyria Data covers patient demographics,
clinical diagnoses, concomitant medications, adverse event monitoring, vital signs, validated clinical assessments, patient reported outcomes and more.

As a result, Emyria Data is a unique source of IP and can provide insights into the safety and efficacy profiles of a wide range of CBD doses and formulations (including low dose CBD) and for a wide range of unmet needs

EMD has an advantage over others in this space,
With so much Real World Data Collected....

This will help with Worldwide Approvals....